A protein chip and kit for active tuberculosis diagnosis
A technology of active tuberculosis and protein chips, applied in biological testing, instruments, measuring devices, etc., to achieve the effect of less specimen consumption, high sensitivity and specificity, and increased stability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0022] Example 1: Determination of protein chip spotting conditions
[0023] 1. Spotting concentration of the capture antibody: the capture antibody (specific antibody for 29 kinds of proteins) in different buffers (sterile water, PBS buffer, PBS containing different concentrations of bovine albumin, PBS containing different concentrations of glycerol) PBS buffer solution, etc.) was diluted at a concentration of 2x, spotted on the surface of the chip with a non-contact spotter, and then compared its activity and stability with a sandwich ELISA method. Experiments show that diluting the capture antibody with PBS buffer containing 0.01-10g / 100ml bovine albumin has the best linear rate and stability.
[0024] 2. Condition control of spotting: when the capture antibody (specific antibody for 29 kinds of proteins) is directly spotted on the surface of the glass slide at room temperature, the spot of the capture antibody is prone to produce hollow spots, and the activity of differen...
Embodiment 2
[0025] Embodiment 2: the preparation of the protein chip kit that is used for active tuberculosis diagnosis of the present invention.
[0026] In order to detect whether there are 29 kinds of proteins in the present invention in the sample, prepare the glass slides that are fixed with specific antibodies against the following 29 kinds of proteins: integrin-like metalloprotease and thrombin 8 (ADAM8), carbohydrate sulfotransferase 4 (CHST4), cytotoxic T lymphocyte-associated antigen 4
[0027](CTLA4), cysteine protease inhibitor E / M (Cystatin E / M), folate receptor 2 (FOLR2), granulocyte colony-stimulating biological factor (GM-CSF), hyaluronan proteoglycan connexin 1 (HAPLN1), interferon alpha / beta receptor 2 (IFNab R2), insulin-like growth factor binding protein 5 (IGFBP-5), interleukin-1R6 (IL-1R6), interleukin-11 (IL-11 ), Interleukin-12p40 (IL-12p40), Interleukin-21R (IL-21R), Interleukin-23 (IL-23), Interleukin-29 (IL-29), Interleukin- 7 (IL-7), kallikrein 14 (Kallikre...
Embodiment 3
[0044] Embodiment 3: the preparation of the polypeptide mixture that stimulates peripheral blood
[0045] In order to ensure the specificity of the stimulating polypeptide, the sequences of two polypeptides were designed according to the CFP-10 and ESAT-6 proteins, see Table 3 for details. The peptide synthesis is completed by Shenzhen Hanyu Biotechnology Co., Ltd., and the purity of the peptide exceeds 95%.
[0046] The source of table 3 polypeptide and and sequence list
[0047]
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com